Stock Market

Stocks in news: Sun Pharma, Tata Motors, Amtek Auto, Aurobindo

Here are stocks that are in news today:

Maruti Suzuki
-Suspends production after fire at Subros unit
-Waiting period for Baleno and Vitara Brezza may increase 

Other stocks and sectors that are in news today:
L&T Infotech withdraws 1500 job offers
-S&P lowers Rolta India ’s term ratings to ‘CCC-‘ from ‘B+’
IOB – S&P downgrades long term issuer credit rating to ‘BB’ from BB+’: FE
Petronet LNG starts talks to redo pricing for Gorgon LNG deal: FE
Raymond forms FMCG unit for premium brands in skin and haircare segments: ET
NCL Industries board approves setting up of ready-mix concrete unit at Hyderabad & Vijaywada (instead of Vishakhapatnam)
Rama Phosphates launched new product – Boronated Single Super Phosphate as powder and granulated at Indore Unit with production capacity of 25,000 TPA
Grindwell Norton board approves 1 bonus share for each held
Simbhaoli Sugars board approves raising up to Rs 75 crore via QIP or rights issue

January-March Quarter Earnings

Sun Pharma Q4FY16 YoY
-Consolidated net profit up 92.7 percent at Rs 1,713.7 crore versus Rs 889.2 crore (YoY)
-Consolidated total income up 24.9 percent at Rs 7,634.2 crore versus Rs 6,112.4 crore (YoY)
-Consolidated EBITDA at Rs 2,520.3 crore versus Rs 794.7 crore (YoY)
-Consolidated EBITDA margin at 33 percent versus 13 percent (YoY)
-Tax expense at Rs 170.6 crore versus Rs 599.9 crore tax reversal (YoY)
-Board to mull share buyback on June 23

Tata Motors Q4
-Consolidated net profit at Rs 5,177 crore versus Rs 1,716.5 crore (YoY)
-Consolidated total income up 19 percent at Rs 80,684 crore versus Rs 67,777 crore (YoY)
-Consolidated EBITDA up 35 percent at Rs 11,387.1 crore versus Rs 8,438 crore (YoY)
-Consolidated EBITDA margin at 14.1 percent versus 12.4 percent (YoY)
-Consolidated exceptional gain at Rs 555.5 crore
-Consolidated forex gain at Rs 71.2 crore versus forex loss of Rs 68.3 crore (YoY)
-JLR net profit up 56.3 percent at £472 million versus £302 million (YoY)
-JLR revenue at £6,594 million versus £5,826 million (YoY)
-JLR EBITDA at £1,069 million versus £1,016 million (YoY)
-JLR EBITDA margin at 16.2 percent versus 17.4 percent (YoY)
-JLR one-time charge £166 million
-Share of China JV profit at £49 million
-Standalone net profit at Rs 465 crore versus loss of Rs 1,164.3 crore (YoY)
-Standalone total income up 16.5 percent at Rs 12,570 crore versus Rs 10,786 crore (YoY)
-Standalone EBITDA at Rs 896 crore versus Rs 159 crore (YoY)
-Standalone EBITDA margin at 7.1 percent versus 1.5 percent (YoY)

Aurobindo Pharma Q4
-Net profit up 39.4 percent at Rs 562.9 crore versus Rs 403.8 crore (YoY)
-Total income up 18.5 percent at Rs 3,746.8 crore versus Rs 3,162.1 crore (YoY)
-EBITDA up 34.5 percent at Rs 882.4 crore versus Rs 565.1 crore (YoY)
-EBITDA margin at 23.6 percent versus 20.7 percent (YoY)

Amtek Auto Q4
-Net loss at Rs 528.7 crore versus profit of Rs 129.8 crore (YoY)
-Total income down 31.8 percent at Rs 651 crore versus Rs 954.7 crore (YoY)
-EBITDA down 52.7 percent at Rs 120.6 crore versus Rs 255 crore (YoY)
-EBITDA margin at 18.5 percent versus 26.7 percent (YoY)
-Exceptional loss at Rs 439.5 crore versus exceptional gain of Rs 180.2 crore (YoY)
-Finance cost at Rs 289.8 crore versus Rs 171.7 crore (YoY)

-Net loss at Rs 1,230.9 crore versus profit of Rs 334.2 crore (YoY)
-Total income down 1.9 percent at Rs 11,371.7 crore versus Rs 11,590.6 crore (YoY)
-EBITDA loss at Rs 1,123.4 crore versus EBITDA profit of Rs 10,914 crore (YoY)